Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-09-22Clinical Trial Update: The Effect of Metformin on Breast Cancer Patients [Phase 2]
Phase 2 clinical trial evaluating the effect of metformin in breast cancer patients.
-
CLINICAL_TRIALS trial_result · 2020-09-21Clinical Trial Update: A Phase II Study to Assess the Efficacy and Safety of SC10914 in the Metastatic Breast Cancer Patients [Phase 2]
Phase II study evaluating SC10914 for metastatic breast cancer with BRCA mutations; results not yet reported.
-
CLINICAL_TRIALS trial_result · 2020-09-21Clinical Trial Update: Mucoadhesive Oral Wound Rinse in Preventing and Treating Stomatitis in Patients With ER- or PR-Positive Metastatic or Locally Recurrent Breast Cancer That Cannot be Removed by Surgery Receiving Everolimus [Phase 2]
Phase 2 clinical trial evaluating a mucoadhesive oral wound rinse to prevent and treat stomatitis in patients with ER- or PR-positive metast…
-
CLINICAL_TRIALS trial_result · 2020-09-18Clinical Trial Update: Trial for Locally Advanced Breast Cancer Using Vorinostat Plus Chemotherapy [Phase 1, Phase 2]
Phase 1/2 trial evaluating vorinostat combined with chemotherapy for locally advanced breast cancer completed; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-09-17Clinical Trial Update: Phase 2 Study of the Monoclonal Antibody MGAH22 (Margetuximab) in Patients With Relapsed or Refractory Advanced Breast Cancer [Phase 2]
Phase 2 study of the monoclonal antibody MGAH22 (margetuximab) in relapsed or refractory advanced breast cancer has completed, and results w…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-09-16Clinical Trial Update: Survivorship Promotion In Reducing IGF-1 Trial [Phase 2]
Phase 2 trial evaluating survivorship promotion by reducing IGF-1 has completed, with results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-09-16Clinical Trial Update: Trial of Active Immunotherapy With Globo H-KLH (OPT-822) in Metastatic Breast Cancer Subjects [Phase 2]
Phase 2 trial of Globo H-KLH (OPT-822) active immunotherapy in metastatic breast cancer completed.
-
CLINICAL_TRIALS trial_result · 2020-09-10Clinical Trial Update: BETH Study: Treatment of HER2 Positive Breast Cancer With Chemotherapy Plus Trastuzumab vs Chemotherapy Plus Trastuzumab Plus Bevacizumab [Phase 3]
Phase 3 trial comparing chemotherapy plus trastuzumab versus chemotherapy plus trastuzumab plus bevacizumab in HER2-positive breast cancer w…
-
CLINICAL_TRIALS trial_result · 2020-09-09Clinical Trial Update: OMT-111 for Terminal Stage Solid Tumors [Phase 2]
Phase 2 trial update for OMT-111 in terminal-stage solid tumors including breast and pancreatic cancer.
-
CLINICAL_TRIALS trial_result · 2020-09-07Clinical Trial Update: Define the Optimal Uptake Time of 68Ga-OPS202 When Used as a PET (Positron Emission Tomography) Imaging Agent in Subjects With Newly Diagnosed Breast Cancer [Phase 2]
Phase 2 clinical trial investigating the optimal uptake time of 68Ga-OPS202 as a PET imaging agent in newly diagnosed breast cancer; study s…
-
CLINICAL_TRIALS trial_result · 2020-09-04Clinical Trial Update: Comparison of One-port and Two-port Tissue Expanders for Breast Reconstruction [NA]
A completed clinical trial comparing one-port versus two-port tissue expanders for breast reconstruction in breast cancer patients; results …
-
CLINICAL_TRIALS trial_result · 2020-09-04Clinical Trial Update: A Study to Assess Preference for Subcutaneous Trastuzumab Treatment in Participants With Human Epidermal Growth Factor Receptor (HER)2-Positive Metastatic Breast Cancer Responding to First-Line Intravenous Trastuzumab for at Least 3 Years [Phase 3]
Phase 3 trial updating preference for subcutaneous versus intravenous trastuzumab in HER2-positive metastatic breast cancer patients respond…
-
CLINICAL_TRIALS trial_result · 2020-09-03Clinical Trial Update: Study of Tislelizumab Plus Chemotherapy vs Chemotherapy as Perioperative Treatment in Participants With HER2 Negative Breast Cancer [Phase 2]
Phase 2 trial evaluating tislelizumab plus chemotherapy versus chemotherapy as perioperative treatment in HER2-negative breast cancer.
-
CLINICAL_TRIALS trial_result · 2020-09-02Clinical Trial Update: Phase 2 Trial of Seribantumab Plus Fulvestrant in Postmenopausal Women With Metastatic Breast Cancer [Phase 2]
Phase 2 trial of seribantumab plus fulvestrant in postmenopausal women with metastatic breast cancer was terminated; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-08-27Clinical Trial Update: A Phase III Trial of Niraparib Versus Physician's Choice in HER2 Negative, Germline BRCA Mutation-positive Breast Cancer Patients [Phase 3]
Phase III trial comparing niraparib to physician's choice in HER2-negative, germline BRCA mutation–positive breast cancer terminated; result…
-
CLINICAL_TRIALS trial_result · 2020-08-25Clinical Trial Update: BrUOG 291: Five Fraction Partial Breast Irradiation Using Non-invasive Image-guided Breast Brachytherapy (NIBB) [NA]
Clinical trial update for BrUOG 291 assessing five-fraction partial breast irradiation using non-invasive image-guided breast brachytherapy …
-
CLINICAL_TRIALS trial_result · 2020-08-24Clinical Trial Update: Dexmedetomidine or Dexmedetomidine Combined With Dexamethasone on Postoperative Nausea and Vomiting in Breast Cancer [NA]
A completed clinical trial evaluating dexmedetomidine alone or with dexamethasone for postoperative nausea and vomiting in breast cancer sur…
-
CLINICAL_TRIALS trial_result · 2020-08-18Clinical Trial Update: Eribulin Plus Cisplatin Versus Gemcitabine Plus Cisplatin in Triple Negative Breast Cancer (TNBC) [Phase 2]
Phase 2 trial comparing eribulin plus cisplatin versus gemcitabine plus cisplatin in triple-negative breast cancer is reported as ongoing wi…
-
CLINICAL_TRIALS trial_result · 2020-08-18Clinical Trial Update: Radiation Therapy in Treating Patients With Recurrent Breast Cancer [NA]
Clinical trial update for radiation therapy in recurrent breast cancer; study status completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-08-14Clinical Trial Update: Doxorubicin Hydrochloride, Cyclophosphamide, and Pacltaxel With or Without Trastuzumab in Treating Women With HER2-Positive Node-Positive or High-Risk Node-Negative Breast Cancer [Phase 3]
Phase 3 trial evaluating doxorubicin, cyclophosphamide, and paclitaxel with or without trastuzumab in HER2-positive breast cancer; study com…
-
CLINICAL_TRIALS trial_result · 2020-08-14Clinical Trial Update: Vinorelbine and Docetaxel in Treating Women With Metastatic Breast Cancer [Phase 2]
Phase 2 clinical trial evaluating vinorelbine and docetaxel in women with metastatic breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2020-08-14Clinical Trial Update: Accelerated Intensity Modulated Radiation Therapy (AIMRT) to the Breast After Segmental Mastectomy [NA]
Completed clinical trial evaluating accelerated intensity modulated radiation therapy to the breast after segmental mastectomy for breast ca…
-
CLINICAL_TRIALS trial_result · 2020-08-13Clinical Trial Update: Neoadjuvant Response-guided Treatment of HER2 Positive Breast Cancer [Phase 2, Phase 3]
A neoadjuvant treatment approach guided by response is being studied in HER2-positive breast cancer across Phase 2 and Phase 3 trials.
-
CLINICAL_TRIALS trial_result · 2020-08-13Clinical Trial Update: A Study of Abemaciclib (LY2835219) With and Without Food in Participants With Metastatic Breast Cancer [Phase 2]
Phase 2 study evaluating abemaciclib (LY2835219) with and without food in metastatic breast cancer has completed; results posted.
-
CLINICAL_TRIALS trial_result · 2020-08-10Clinical Trial Update: A Study of Fluzoparib±Apatinib Versus Chemotherapy Treatment of Physician's Choice in HER2-negative Metastatic Breast Cancer Patients With Germline BRCA Mutation [Phase 3]
Phase 3 clinical trial updating the study of Fluzoparib with or without Apatinib versus chemotherapy in HER2-negative metastatic breast canc…